Other links & information
- ANZTPA-UPDATE email archive
- ANZTPA project newsletters
- Clinical trials & unapproved therapeutic goods
- Committees
- Cosmetics
- Food-medicine interface
- Packaging
- Regional harmonisation
- Treaty & other documents related to the project
Clinical trials & unapproved therapeutic goods
- Consultation paper on the proposed clinical trial regulatory arrangements under ANZTPA
- Regulatory arrangements for clinical trials and access to unapproved therapeutic products
Committees
- Advertising Implementation Steering Group
- Interim Advertising Council
- Interim Joint Expert Advisory Committee on Complementary Medicines
- Joint Expert Committee on Labelling Requirements for Medicines
- Joint Interim Expert Advisory Committee on Standards
Cosmetics
Food-medicine interface
Packaging
- Draft Order: Packaging Requirements for Specified Therapeutic Products
- Child-resistant packaging requirements for therapeutic goods
Regional harmonisation
Treaty & other documents related to the project
- Text of the treaty: Agreement between the Government of Australia and the Government of New Zealand for the establishment of a joint scheme for the regulation of therapeutic products (pdf, 79kb)
- Joint documents relating to the project
- Australian documents relating to the project
- April 2007: Therapeutic Products Bill 2007 - Exposure Draft (Department of Health & Ageing website)
- March 2004: Parliament of Australia Joint Committee - Australian treaty examination process (includes a Regulation Impact Statement and National Impact Analysis on the Agreement between Australia and New Zealand for the Establishment of a Joint Scheme to Regulate Therapeutic Products)
- New Zealand documents relating to the project
- December 2006: Therapeutic Products and Medicines Bill (New Zealand Parliament website)
- March 2004: National Interest Analysis on the Agreement Between the Government of Australia and the Government of New Zealand for the Establishment of a Joint Scheme for the Regulation of Therapeutic Products
- September 2003: Regulatory Impact Statement
- November 2002: Regulatory Impact Statement on a proposal for a trans Tasman agency to regulate therapeutic products
- October 2002: Assessment of regulatory options for therapeutic products - report to the trans-Tasman working group

